Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: A randomized, phase-II study-Reference-Cited by-同舟云学术

Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: A randomized, phase-II study

Published:2012-09 Issue:3 Volume:77 Page:550-555
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kusagaya Hideki,Inui Naoki,Karayama Masato,Nakamura Yutaro,Kuroishi Shigeki,Yokomura Koshi,Toyoshima Mikio,Shirai Toshihiro,Masuda Masafumi,Yamada Takashi,Yasuda Kazumasa,Suda Takafumi,Chida Kingo

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths;Siegel;CA Cancer J Clin,2011

3. Aging and cancer: issues of basic and clinical science;Ershler;J Natl Cancer Inst,1997

4. Chemotherapy for elderly patients with non-small cell lung cancer: a review of the evidence;Gridelli;Chest,2005

5. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database;Owonikoko;J Clin Oncol,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pemetrexed-based first-line chemotherapy had particularly prominent objective response rate for advanced NSCLC: A network meta-analysis;Open Medicine;2021-01-01

2. Short‐Term Efficacy of Different First‐Line Chemotherapy Regimens for Advanced Non‐Small Cell Lung Cancer: A Network Meta‐Analysis;Clinical and Translational Science;2020-02-27

3. Meta-analysis comparing doublet and single cytotoxic agent therapy as first-line treatment in elderly patients with advanced nonsmall-cell lung cancer;Journal of International Medical Research;2015-10-05

4. Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations;Cancer Chemotherapy and Pharmacology;2015-05-24

5. Incidence of Hematologic Toxicity in Older Adults Treated with Gemcitabine or a Gemcitabine-Containing Regimen in Routine Clinical Practice: A Multicenter Retrospective Cohort Study;Drugs & Aging;2014-09-13